Bhadrapura Lakkappa Dhananjaya

Bhadrapura Lakkappa Dhananjaya

Auto-generated profile, based on publicly available information

Bhadrapura Lakkappa Dhananjaya

Jain University

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
YSYallappa Shiralgi
Yallappa Shiralgi
MJManjanna Jayappa
Manjanna Jayappa
BDB.L. Dhananjaya
B.L. Dhananjaya

1 July 2005 in Toxicon
Verified
Journal Article
Closed access
RRR. Rajesh
R. Rajesh
CGC.D. Raghavendra Gowda
C.D. Raghavendra Gowda
ANA. Nataraju
A. Nataraju
BDB.L. Dhananjaya
B.L. Dhananjaya
KKK. Kemparaju
K. Kemparaju
BVB.S. Vishwanath
B.S. Vishwanath

23 February 2010 in Cell Biochemistry and Function
Verified
Journal Article
Closed access
PDF file
BDBhadrapura L. Dhananjaya
Bhadrapura L. Dhananjaya
CDCletus J. M. D'SOuza
Cletus J. M. D'SOuza

1 September 2006 in Toxicon
Verified
Journal Article
Closed access
BDB.L. Dhananjaya
B.L. Dhananjaya
ANA. Nataraju
A. Nataraju
RRR. Rajesh
R. Rajesh
CGC.D. Raghavendra Gowda
C.D. Raghavendra Gowda
BSB.K. Sharath
B.K. Sharath
CDCletus J.M. D’sOuza
Cletus J.M. D’sOuza

1 January 2010 in Biochemistry (Moscow)
Verified
Journal Article
Closed access
PDF file
BDB. L. Dhananjaya
B. L. Dhananjaya
CDC. J. M. D’SOuza
C. J. M. D’SOuza
In this review, we have compiled the data on pharmacological activities associated with endogenous purine release related enzymes—nucleases (DNases, RNases, and phosphodiesterases). The results of studies on toxic effects of these enzymes, emphasizing the future directions in this field, are summarized. One of the major problems facing toxicologists is the identification and characterization of specific venom nucleases since they share similar substrate specificities and biochemical properties. In this review, we have attempted to clarify some of the discrepancies about these enzymes. Further, we have tried to correlate the existence of nuclease enzymes in relation to endogenous release of purines, a multitoxin, during snake envenomation, and we also discuss the possible actions of purines. We hope that this review will stimulate renewed interest among toxicologists to biologically characterize these enzymes and elucidate their role in envenomation.

1 July 2016 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SPSwathi Putta
Swathi Putta
NYNagendra Sastry Yarla
Nagendra Sastry Yarla
EKEswar Kumar Kilari
Eswar Kumar Kilari
CSChalla Surekha
Challa Surekha
Gjumrakch AlievGjumrakch Aliev
Gjumrakch Aliev
BDBhadrapura Lakkappa Dhananjaya
Bhadrapura Lakkappa Dhananjaya
Diabetes is a major chronic metabolic disorder globally and around of 285 million people are affected by the disease and the number is expected to double in the next two decades. The major focus of anti-diabetic therapies is to enhance insulin production, sensitivity and/or reduce the blood glucose level. Although several synthetic drugs have been developed as antidiabetic agents but their utility has been hampered due to their side effects and poor efficacy. In this scenario, research on natural products has been gained importance due their safety profile in toxicity studies. Terpenoids belong to an important class of natural products and several terpenoids have been reported as antidiabetic agents. Some of them are under various stages of pre-clinical and clinical evaluation to develop them as antidiabetic agents. These agents can inhibit enzymes responsible for the development of insulin resistance, normalization of plasma glucose and insulin levels and glucose metabolism. Triterpenes can act as promising agents in the treatment of diabetic retinopathy, neuropathy and nephropathy or in impaired wound healing by inhibiting several pathways involved in the diabetes and associated complications. However, efforts in understanding the biological actions and clinical studies involving the applications of triterpenes in treating diabetes are very limited. Hence, special attention is imperative to explore the therapeutic potential of these compounds and provide new information to the scientific community. This review aims to provide the recent advances in triterpenes chemistry, its derivatives, biological interventions and its therapeutic applications with special emphasis on diabetes and its associated disorders.